M. Rosseneu

4.3k total citations
112 papers, 3.6k citations indexed

About

M. Rosseneu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, M. Rosseneu has authored 112 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Endocrinology, Diabetes and Metabolism, 40 papers in Surgery and 31 papers in Molecular Biology. Recurrent topics in M. Rosseneu's work include Diabetes, Cardiovascular Risks, and Lipoproteins (40 papers), Lipoproteins and Cardiovascular Health (26 papers) and Cancer, Lipids, and Metabolism (18 papers). M. Rosseneu is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (40 papers), Lipoproteins and Cardiovascular Health (26 papers) and Cancer, Lipids, and Metabolism (18 papers). M. Rosseneu collaborates with scholars based in Belgium, France and United States. M. Rosseneu's co-authors include Guy De Backer, R. Vercaemst, N Vinaimont, Christine Labeur, J.P. Van Biervliet, J Bury, J.P. Deslypère, F. M. Belpaire, Hans Caster and Berlinda Vanloo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

M. Rosseneu

112 papers receiving 3.5k citations

Peers

Countries citing papers authored by M. Rosseneu

Since Specialization

Citations

This map shows the geographic impact of M. Rosseneu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rosseneu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rosseneu more than expected).

Fields of papers citing papers by M. Rosseneu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rosseneu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rosseneu. The network helps show where M. Rosseneu may publish in the future.

Co-authorship network of co-authors of M. Rosseneu

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rosseneu. A scholar is included among the top collaborators of M. Rosseneu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rosseneu. M. Rosseneu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of the aggregation properties, secondary structure and apoptotic effects of wild‐type, Flemish and Dutch N‐terminally truncated amyloid β peptides 2001 ·European Journal of Neuroscience ·N. Demeester, (unknown), Hans Caster, Marc Goethals, Joël Vandekerckhove, M. Rosseneu, Christine Labeur	30
2	Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study 1999 ·Atherosclerosis ·Jean Dallongeville, Laurence Tiret, Sophie Visvikis‐Siest, (unknown), (unknown), (unknown), M. Rosseneu, G DeBacker, Steve E. Humphries, Ulrike Beisiegel	37
3	Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-β particle in type 2 diabetic patients 1999 ·Clinica Chimica Acta ·Fernando Brites, (unknown), Catherine De Geitere, Nathalie Nicolaı̈ew, B Jacotot, M. Rosseneu, Jean‐Charles Fruchart, (unknown), Graciela Castro	26
4	A proposed architecture for lecithin cholesterol acyl transferase (LCAT): Identification of the catalytic triad and molecular modeling 1998 ·Protein Science ·Frank Peelman, N Vinaimont, Berlinda Vanloo, Christine Labeur, M. Rosseneu, Annick Verhee, (unknown), (unknown), Jan Tavernier, (unknown), Nicolas Duverger, Gillian Hutchinson	82
5	Dietary Nucleotides Enhance Plasma Lecithin Cholesterol Acyl Transferase Activity and Apolipoprotein A-IV Concentration in Preterm Newborn Infants 1995 ·Pediatric Research ·Antonio Sánchez–Pozo, Manuel Ramı́rez, Ángel Gil, J. Maldonado, J.P. Van Biervliet, M. Rosseneu	34
6	Helix-helix interactions in reconstituted high-density lipoproteins 1995 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Laurence Lins, Robert Brasseur, Michel De Pauw, J.P. Van Biervliet, (unknown), M. Rosseneu, Berlinda Vanloo	21
7	Diet and the essential fatty acid status of term infants 1994 ·Acta Paediatrica ·Gerhard Kohn, G Sawatzki, (unknown), M. Rosseneu	30
8	Changes in biological activity and immunoreactive mass of lipoprotein lipase in congenital nephrosis: relationship to hypertriglyceridaemia 1993 ·European Journal of Clinical Investigation ·Marjatta Antikainen, C. G. Holmberg, Thomas Olivecrona, Gunilla Bengtsson-Olivecrona, Christine Labeur, M. Rosseneu, Marja‐Riitta Taskinen	8
9	Announcement 1992 ·Atherosclerosis ·(unknown), Rudolf Zechner, Victor W. Armstrong, Steve E. Humphries, M. Rosseneu, (unknown)	1
10	Plasma apolipoprotein A‐IV metabolism in patients with chronic renal disease 1992 ·European Journal of Clinical Investigation ·Hans Dieplinger, (unknown), Paul König, Helmut Graf, C. Sandholzer, E Matthys, M. Rosseneu, Gerd Utermann	29
11	Structural and functional properties of apolipoprotein B in chemically modified low density lipoproteins 1992 ·Atherosclerosis ·(unknown), (unknown), Johan Baert, Berlinda Vanloo, Laurence Lins, Jean Marie Ruysschaert, M. Rosseneu	28
12	Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations 1992 ·Human Genetics ·(unknown), M. Rosseneu, David Robinson, (unknown), J.P. Deslypère, Steve E. Humphries	86
13	Lipoprotein(a) profiles and evolution in newborns 1991 ·Atherosclerosis ·J.P. Van Biervliet, Christine Labeur, (unknown), David Usher, M. Rosseneu	26
14	Effect of simvastatin treatment on the dyslipoproteinemia in capd patients 1991 ·Atherosclerosis ·E Matthys, M. Schurgers, G. Lamberigts, Norbert Lameire, (unknown), Christine Labeur, Ulrike Beisiegel, M. Rosseneu	18
15	Determinants of fat consumption in a general population. 1990 ·PubMed ·(unknown), Guy De Backer, Marcel Kornitzer, S. De Henauw, (unknown), M. Rosseneu, R. Vercaemst	6
16	Mode of assembly of amphipathic helical segments in model high-density lipoproteins 1990 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Robert Brasseur, Joëlle De Meutter, Berlinda Vanloo, Erik Goormaghtigh, Jean Marie Ruysschaert, M. Rosseneu	97
17	Separation and quantitation of free cholesterol and cholesteryl esters in a macrophage cell line by high-performance liquid chromatography 1989 ·Journal of Chromatography B Biomedical Sciences and Applications ·R. Vercaemst, Ann Union, M. Rosseneu	44
18	Quantitation of plasma free cholesterol and cholesteryl esters by high performance liquid chromatography Study of a normal population 1989 ·Atherosclerosis ·R. Vercaemst, Ann Union, M. Rosseneu, (unknown), Guy De Backer, Marcel Kornitzer	38
19	Changes in plasma lipids and apoproteins associated with physical training in middle-aged sedentary men 1988 ·American Heart Journal ·Peter Hespel, Paul Lijnen, Robert Fagard, R Van Hoof, M. Rosseneu, A. Amery	21
20	Isolation and Characterization of Lipoprotein Profiles in Newborns by Density Gradient Ultracentrifugation 1983 ·Pediatric Research ·M. Rosseneu, J.P. Van Biervliet, J Bury, N Vinaimont	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact